Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome FoundfiledCriticalWellcome Found
Publication of ECSP931002ApublicationCriticalpatent/ECSP931002A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Se refiere a una combinación de atovacuonna y proguanil, a su uso en el tratamiento y profilaxis de infecciones parasitarias, tales como infecciones parasitarias protozoarias, por ejemplo, malaria y toxoplasmosis e infecciones ocasionadas por P.carinil y a su uso en la manufactura de medicamentos para el tratamiento y/o profilaxis de dichas infecciones.Refers to a combination of atovacuonna and proguanil, its use in the treatment and prophylaxis of parasitic infections, such as protozoal parasitic infections, for example, malaria and toxoplasmosis, and infections caused by P. carinil, and its use in the manufacture of medicines for the treatment and / or prophylaxis of said infections.
ANALOG COMPOUNDS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL, PROCESS FOR PREPARATION, USE IN THE TREATMENT OF VIRAL INFECTIONS, AND PACKING THAT CONTAINS THEM